Eli Lilly said Monday it will spend up to $7 billion to buy privately held Kelonia Therapeutics for its suite of cancer treatments.

Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products, today announced upcoming presentations at the ...

Kelonia is developing technology to reprogram patients' T-cells inside the body so those cells can attack cancer, called in ...

If you happen to keep up with Ford’s F-150, then you might have already been aware of complaints that have been circulating ...

Medical oncologist (ex AstraZeneca, MorphoSys, Autolus Therapeutics) joins to advance Asgard’s lead asset AT-108 into Phase 1 ...

Q: My 2017 Infiniti GX50 has doors that auto lock at 5 mph. The problem is that frequently I would like to allow my wife to exit the car while ...

A Twin Cities locksmith says the same tools he uses to help stranded drivers are now being misused by thieves to steal cars in seconds, sometimes from several feet away.

After several weeks of development, Hyundai has released a solution for the Palisade’s well-publicized rear-seat issues.

The Insurance Institute for Highway Safety first began releasing crash-test ratings in 1995 and introduced the TSP rating in 2006. To get a TSP rating in 2026, vehicles must earn: • A rating of Good ...

One of the most advanced cancer treatments available today may soon get a major upgrade. CAR-T therapy has already saved lives, but it remains complex, expensive, and difficult to access. Now, ...

Manufacturing CAR T cell therapy—one of the most powerful weapons against certain blood cancers—has to date involved an elaborate process, through which doctors first extract a patient’s immune cells ...

The most common side effects of mRNA vaccines like the COVID-19 shot are well known: soreness, mild fever, and general malaise. Those symptoms, which typically resolve within days, are the natural ...